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Bacterial adenosine diphosphate-ribosyltransferases (ADPRTs) are toxins that play a signifi-
cant role in pathogenicity by inactivating host proteins through covalent addition of ADP-
ribose. In this study we used ADP-ribosylated Kemptide (LRRASLG) as a standard to examine
the effectiveness of three common tandem mass spectrometry fragmentation methods for
assignment of amino acid sequence and site of modification. Fragmentation mechanisms
investigated include low-energy collision-induced dissociation (CID), infrared multiphoton
dissociation (IRMPD), and electron-capture dissociation (ECD); all were performed on a
hybrid linear ion trap Fourier transform ion cyclotron resonance mass spectrometer. We show
that ECD, but neither CID nor IRMPD, of ADP-ribosylated Kemptide produces tandem mass
spectra that are interpretable with regard to amino acid sequence assignment and site of
modification. Examination of CID and IRMPD tandem mass spectra of ADP-ribosylated
Kemptide revealed that fragmentation was primarily focused to the ADP-ribose region,
generating several potential diagnostic ions for use in discovery of ADP-ribosylated proteins.
Because of the lower relative sensitivity of ECD during data-dependent acquisition to CID, we
suggest a 2-fold strategy where CID and IRMPD are first used to detect ADP-ribosylated peptides,
followed by sequence assignment and location of modification by ECD analysis. (J Am Soc Mass
Spectrom 2009, 20, 477–483) © 2009 Published by Elsevier Inc. on behalf of American Society for
Mass SpectrometryAdenosine diphosphate-ribosyltransferases(ADPRTs) catalyze the transfer of ADP-ribosefrom -NAD to target proteins (Scheme 1),
commonly at arginine residues [1]. Members of the
ADPRT family modify a diverse set of target proteins and
share little sequence homology. The mammalian ADP-
ribosyltransferase ART-1 modifies defensin-1, which
ultimately blocks the antimicrobial and cytotoxic effects
of the defensin HNP-1 [2]. Many ADPRTs found in
bacteria have been implicated in pathogenicity through
the inactivation of host proteins (e.g., Vibrio cholera,
Bordetella pertussis, and Streptococcus pyogenes [1]). S.
pyogenes produces the ADPRT toxin SpyA, which mod-
ifies vimentin, actin, and tropomyosin, all proteins
involved in cytoskeletal structure [3]. ADP-ribosylation
of these proteins prevents polymerization of the cy-
toskeleton, leading to collapse of intermediate fila-
ments. Other ADPRT toxins are known to target proteins
involved in signal transduction and regulatory functions
[1]. Although there are numerous molecular assays
demonstrating that ADP-ribosylation is an important
step in pathogenicity, to date the exact site of ADP-
ribosylation and number of modification targets re-
mains unknown for many ADPRTs. A high-throughput
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of target proteins as well as sites of ADP-ribosylation
would provide insight into mechanisms of infection.
Often liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) methods are used to identify
sites and protein targets of post-translational modifica-
tions (PTMs) in complex biological samples [4, 5].
Collision-induced dissociation (CID) is typically used as
the main fragmentation method during LC-MS/MS
analyses because the instrumental duty cycle is high
and acquired peptide tandem mass spectra may be
easily sequenced. This primarily results from the pre-
dictable peptide fragmentation pathways [6], allowing
for identification of the parent proteins [7]. However,
the presence of a PTM on a peptide can redirect CID
fragmentation patterns such that sequence may not be
assigned. Previously, Margarit et al. [8] demonstrated
that CID of an ADP-ribosylated peptide did not result
in “typical” peptide fragmentation, interfering with
facile sequence interpretation. Additionally, CID anal-
ysis of SpyA ADP-ribosylated Vimentin [3] verified
similar fragmentation trends, preventing modified pep-
tide sequence assignment (S. M. Hengel, unpublished
data). The inability to directly assign peptide sequences
of ADP-ribosylated peptides using CID led us to un-
dertake a detailed mass spectrometry fragmentation
pattern analysis of a standard, ADP-ribosylated Kemp-
tide (LRRASLG). Three common fragmentation meth-
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dissociation (ECD), and (3) infrared multiphoton disso-
ciation (IRMPD).
The goals of this study were to determine the most
efficient technique for producing reliable and predict-
able fragment-ion spectra for the identification of ADP-
ribosylated peptides and to determine whether diag-
nostic ions exist that might be used in future studies to
identify new ADPRT targets. ADP-ribosylated Kemp-
tide was chosen as a standard for examining which of
the three methods—CID, ECD, and IRMPD—were best
suited to (1) assign amino acid sequence and (2) pro-
duce ions diagnostic of ADP-ribosylation. Here we
discuss the results of this comparison and how these
methods may be used alone and in combination to
identify ADP-ribosylated proteins in complex mixtures.
Experimental
ADP-Ribosylation of Peptide Standard
Reagents used for peptide modification were obtained
from Sigma (St. Louis, MO, USA). A 5 mM solution of
Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly, MW 771.4715)
was modified as previously described [9], in the pres-
ence of 10 mM ADP-ribose, 20 mM DTE, and 100 mM
Scheme 1. ADPRTs catalyze the transfer of ADP-ribose to accep-
tor proteins from NAD.phosphate buffer at 33 °C for 4 h. After incubation, theextent of ADP-ribosylation was determined by compar-
ing peak height and area of extracted ion chromato-
grams for modified and unmodified Kemptide precur-
sor masses following separation on a C18 column
described in the following text.
Electrospray Ionization LTQ-FT-based Mass
Spectrometry
Peptides were analyzed using electrospray ionization
(ESI) in a linear ion trap Fourier transform ion cyclotron
resonance cell mass spectrometer (LTQ-FT-ICR) (Thermo
Electron Corp., San Jose, CA, USA). HPLC columns
were packed in-house (0.75 m i.d.  11 cm; 100-Å
Magic C18AQ: Michrom Bioresources, Auburn, CA,
USA) and separations were performed with an inline
Agilent 1100 binary HPLC pump (Agilent Technolo-
gies, Palo Alto, CA, USA) using a linear gradient of 5 to
35% ACN over 1 h. ESI voltage was applied with a
liquid junction before the analytical column with a gold
wire and a micro-tee junction [10]. All ions were mea-
sured in positive-ion mode, both precursor and frag-
ment masses were detected in the FT mass analyzer.
Source parameters were set as follows: ESI voltage, 2.5
kV; capillary temperature, 265 °C; capillary voltage, 13
V; tube lens, 35 V. For all fragmentation methods the
resolution was set to 5.0e4 and 2.0e4 for MS and MS/
MS, respectively. Automatic gain control was used to
maintain constant ion populations at 5e5 and 2e5 for MS
and MS/MS, respectively.
Fragmentation Methods
Reported tandem mass spectra for both modified and
unmodified Kemptide are from doubly charged precur-
sor masses 657.27 and 386.74 m/z, respectively; tandem
mass spectra were acquired in the FT-ICR cell during
LC-MS/MS analysis. Fragment ion spectra acquired
with CID were produced using 35% collision energy
and a 2.0 Da isolation window. ECD tandem mass
spectra were acquired using 5 eV fragmentation energy
for 70 ms with a delay of 0.3 ms and a 3.0 Da isolation
window. IRMPD was performed by irradiating precur-
sor ions with photons produced by a CO2 laser [Synrad
firestar series V20, model FSV20SFB; 75 Watts (10.2–10.8
m)] with a pulse duration of 50 ms, a power of 60%,
and an isolation window of 5.0 Da.
Limit of Detection
To determine the limit of detection of ADP-ribosylated
Kemptide in a complex mixture, a bovine serum albu-
min (BSA) peptide standard was used to dilute the
analyte (Michrom Bioresources). BSA was maintained
at a concentration of 5 pmol/L and serial dilutions of
the analyte were initiated with a 1:1 ratio of BSA to
ADP-ribosylated Kemptide. ADP-ribosylated Kemptide
concentrations ranged from 2.5 pmol/L to 250 amol/
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1:50; 1:100 . . .). Samples were analyzed using data-
dependent LC-MS/MS conditions described earlier, se-
lecting the five most intense peaks observed in the MS
spectrum for MS/MS, acquiring both CID and IRMPD
data for each dilution.
Results and Discussion
Collision Induced Dissociation (CID)
The process of conducting CID combined with auto-
mated, data-dependent ion selection provides a fast
duty cycle that is well suited for LC-based analysis of
mixtures and is therefore commonly used in proteomics
[7]. However, the CID-generated tandem mass spec-
trum of ADP-ribosylated Kemptide contains none of the
observed b or y ions in the unmodified Kemptide CID
tandem mass spectrum (Figure 1a) making sequence
and site of ADP-ribosylation assignment impossible
(Figure 1b). Close examination of the APD-ribosylated
Kemptide CID tandem mass spectrum revealed several
ions not accountable by Kemptide peptide backbone
fragmentation (Figure 1b). Based on accurate mass
measurements, the known structure of ADP-ribose, and
Kemptide amino acid sequence, most of these ions
appear to be formed through fragmentation of the
ADP-ribose region.
Figure 1. Collision-induced dissociation tandem mass spectra of
(a) Kemptide and (b) ADP-ribosylated Kemptide.ADP-ribose contains ten single bonds, excluding
cross-ring fragmentation, which can yield fragment
ions. To keep track of fragment ions occurring on the
ADP-ribose backbone, we suggest the nomenclature
shown in Scheme 2. Fragment ions with charge retained
on the ADP-ribose group, but with loss of the peptide,
are labeled m1 . . . m10 for modification. Fragment ions
that contain part of the ADP-ribose region plus the
intact peptide backbone are labeled p1 . . . p10. We do
not show any cross-ring fragmentation sites labeled in
Scheme 2 because none was observed in our studies.
However, we realize that such fragments might be
formed by some future fragmentation method or com-
bination of current methods. For these potential frag-
ment ions we propose the use of a variation on the
carbohydrate fragmentation nomenclature proposed by
Domon and Costello [11]. In place of the subscript
number for single bond fragments, rings are assigned a
Roman numeral (i.e., I for the ribose closest to the
peptide, then II, etc.), and cross-ring fragments are
noted using numbers indicating which cross-ring bonds
are broken. Similar to the single bond fragments along
ADP-ribose, m and p will be used to designate on which
side the charge is observed. For example, a fragmenta-
Scheme 2. ADP-ribose fragmentation scheme: fragment ions
containing the intact peptide backbone plus a portion of the
modification are labeled p1 through p10. Fragment ions indepen-
dent of the peptide sequence, only containing the ADP-ribose
modification, are labeled m1 through m10.tion event at the ribose ring, adjacent to the guanidine
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be designated as 0,2pI or
0,2mI, depending on which side
the charge is observed. The ADP-ribosylated Kemptide
CID tandem mass spectrum contains an observed ion at
m/z 348, labeled m6 (Scheme 2), which results from
fragmentation of the APP-ribose pyrophosphate bond.
This fragmentation generates two types of ions ex-
plained with structures where charge is retained on
both sides of the cleavage site. The measured mass
difference for the ion labeled m6 and that of the putative
structural assignment is calculated to be 1.7 ppm,
strongly suggesting the assignment is correct. We also
note that previously reported results of CID ADP-
ribosylated peptides [8] yielded similar fragment ions
localized between ribose and the phosphate group
proximal to the peptide backbone, again suggesting that
the ADP-ribose modification “directs” the CID frag-
mentation process of ADP-ribosylated peptides.
Further examination into the origin of other promi-
nent ions in Figure 1b (i.e., the base peak) suggests that
such ions are complementary fragments to the ion at
348 m/z and an additional fragment near the adenine
portion of the ADP-ribose group (fragments labeled p5,
p10; Scheme 2). Unlike the ion at 348 m/z, which appears
to be charged fragments of ADP-ribose without peptide
attached, ions p5 and p10 contain a mass equal to that of
Kemptide plus a residual mass from ADP-ribose frag-
mentation. Charge states of this type of fragment ion
are equivalent to the initial charge state minus the loss
of the protonated ADP-ribose fragment. Because it is
not a neutral loss, often seen in CID with other post-
translational modifications like phosphorylation [5], the
charge state of the observed fragment ions may vary.
Therefore, we predict that CID spectral complexity of
ADP-ribose modified peptides will increase directly
with amino acid number and charge state of the pre-
cursor peptide.
Although the CID tandem mass spectrum of ADP-
ribosylated Kemptide contains ions that may be diag-
nostic of ADP-ribose, the spectrum does not contain
any information on peptide sequence, as seen in the
associated CID tandem mass spectrum of Kemptide
(Figure 1a). In an attempt to understand what single
tandem mass spectrometry method, or combination of
methods, provides full interpretation of peptide se-
quence, site of modification, and generates potential
diagnostic ions, we investigated the fragmentation of
Kemptide and ADP-ribosylated Kemptide by ECD and
IRMPD.
Electron Capture Dissociation (ECD)
Compared with the CID tandem mass spectrum (Figure
1a), a more complete ion series is observed with ECD
fragmentation on the unmodified Kemptide standard
(Figure 2a). During ECD one charge on the peptide is
neutralized due to the capture of an electron. As a
result, peptides that are initially doubly charged retain a
charge on only one of the fragment ion products; thusboth complete c or z ion series may not be detected (Figure
2a). Therefore, larger peptides with higher charge states
should have a greater probability to produce both c and z
ions upon ECD fragmentation, increasing the opportu-
nity for assigning post-translational modification sites.
A distinguishing feature of ECD is the retention of
peptide side-chain modifications [12–14]. Predictably,
we see in our ECD data of ADP-ribosylated Kemptide
(Figure 2b) that ADP-ribose is retained on the arginine
side chain. Additionally, the ECD tandem mass spec-
trum of ADP-ribosylated Kemptide contains three of six
predicted c ions and one of six z peptide fragment ions
within 10 ppm mass accuracy of the calculated theoret-
ical values. As a result, peptide sequence and the site of
ADP-ribosylation can be elucidated from the ECD tan-
dem mass spectrum. The Kemptide amino acid se-
quence contains two arginine residues and, using ECD,
we were able to localize the site of modification to the
second amino acid, i.e., LR*RASLG, where R*  argi-
nine ADP-ribosylated on the guanidinium amino
group. In contrast to the CID tandem mass spectrum,
only two observed ions of lower intensity correlate to
fragmentation of the ADP-ribose group in the ECD
Figure 2. Electron capture dissociation tandem mass spectra of
(a) Kemptide and (b) ADP-ribosylated Kemptide.tandem mass spectrum (fragment p1 and p5, Figure 2b).
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Kemptide, a minimal amount of the ECD energy is
directed to ADP ribose and the majority of energy is
directed to fragmentation of the peptide NOC amide
backbone in a predictable manner. Thus, ECD is a
reliable fragmentation method that can provide infor-
mation for peptide sequencing and site assignment of
ADP-ribosylated Kemptide.
Infrared Multiphoton Dissociation (IRMPD)
As expected, the IRMPD fragment ion spectrum of the
unmodified Kemptide peptide standard contains b and
y ions, as well as a diagnostic immonium ion (Figure
3a). Despite the fact that both CID and IRMPD generate
fragment ions through an increase in vibrational en-
ergy, there is a noticeable difference between the un-
modified Kemptide CID and IRMPD tandem mass
spectra. One likely source of this variation is the time-
of-flight effect observed for CID fragment ions gener-
ated in the LTQ and subsequently transmitted to the
ICR cell, as opposed to IRMPD fragment ions that are
both generated and measured in the ICR cell [15].
Compared to the unmodified Kemptide ECD tandem
mass spectrum, the observed IRMPD ion series is less
complete—peptide sequencing of this short peptide
would be challenging. Implementation of IRMPD frag-
Figure 3. Infrared multiphoton dissociation tandem mass spec-
tra of (a) Kemptide and (b) ADP-ribosylated Kemptide.mentation on ADP-ribosylated Kemptide produced a
tandem mass spectrum with only one fragment ion, y5,
corresponding to peptide backbone fragmentation (Fig-
ure 3b). Upon further analysis, the IRMPD tandemmass
spectrum base peak, 136 m/z, is not a result of peptide
backbone fragmentation, but instead is the complement
of fragment ion p10 (Scheme 2) found in the CID
spectrum. This ion, m1, appears to result from the loss
of adenine from ADP-ribose, is independent of peptide
sequence, and confirmed again using 1 ppm mass
error.
Distinct from the ADP-ribosylated Kemptide ECD
spectrum and the unmodified Kemptide IRMPD spec-
trum, the precursor ion is no longer observed when
using IRMPD to fragment ADP-ribosylated Kemptide.
This may be due to the ease in which the ADP-ribose
group fragments, as seen in the CID tandem mass
spectrum, and an increase of photon absorptivity [16],
making the fragmentation more efficient for an ADP-
ribose group when compared with a peptide backbone.
Potential Diagnostic Ions of ADP-ribosylated
Peptides
Both IRMPD and CID fragmentation techniques gener-
ated ions independent of the Kemptide amino acid
sequence, i.e., 136 and 348 m/z, respectively, yet specific
to ADP-ribose. One of these ions, 348 m/z, was previ-
ously observed using CID to study an ADP-ribosylated
actin peptide [8]. In addition, CID tandem mass spec-
trometry generated fragment ions that are indicative of
an ADP-ribose modification and dependent on peptide
sequence. Ions such as these are potentially diagnostic
of ADP-ribose modifications on a peptide and may be
useful in discovery-based proteomic screens that seek to
identify targets of ADPRTs. However, because neither
CID nor IRMPD produced fragment ions that lead to
peptide sequence assignment, precursor ions identified
containing ADP-ribose in an initial CID or IRMPD
screening analysis would need to be further subjected to
ECD fragmentation. There are two primary benefits of
using CID over ECD or IRMPD in the initial discovery
of ADP-ribosylated peptide precursor ion masses: (1)
ions that are dependent on and independent of peptide
precursor ion mass to charge ratios are produced,
providing multiple fragment ions indicative of ADP-
ribosylated peptides, thus reducing the false discovery
rate; and (2) duty cycle is high, when acquired in an
LTQ, relative to IRMPD and ECD, providing better
analytical sampling for detection of ADP-ribosylated
peptides. However, in this study all fragment ions were
measured in the FT-ICR cell to generate high confidence
structure assignments. When analyzing samples with a
large dynamic range where sensitivity is crucial to
detection, IRMPD should provide two advantages: (1)
the IRMPD-produced diagnostic ion at 136 m/z is the
base peak of the tandem mass spectrum and (2) ions are
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CID and IRMPD have unique benefits when searching
for diagnostic ions in tandem mass spectra. Provided
sample availability and sufficient instrument access, we
suggest performing both CID and IRMPD LC-MS/MS
experiments measuring fragment masses in the ICR cell
generating high mass accuracy data. If CID fragments
were generated and measured in the LTQ while IRMPD
fragmentation occurs in the FT-ICR, then both data
could be acquired in a single run with minimal reduc-
tion in duty cycle. However, compared with measuring
fragment ions in the ICR cell, the loss of mass accuracy
for CID fragment ions acquired in the LTQ would be
substantial. Given that no neutral loss trigger is possible
with the observed type of fragment ions, a discovery-
based screen designed to detect ADP-ribosylated pep-
tides would need to be conducted in two LC-MS/MS
experiments. First, a typical data-dependent experiment
would be performed using CID, and/or IRMPD and,
second, an ECD experiment using an inclusion list
based on the first experiment would be completed.
When MS-driver software advances to allow on-the-fly
switching from CID/IRMPD to ECD with this type of
diagnostic ion, then the discovery and identification of
ADP-ribosylated peptides could be conducted in a single
LC-MS/MS experiment.
Testing Diagnostic Ions
Spiking ADP-ribosylated Kemptide into a complex mix-
ture simulated an experiment designed to discover new
targets of ADPRTs. These analyses also allowed us to
test the proposed diagnostic ions and establish a limit of
detection. Three proposed ions diagnostic of ADP-
ribosylated peptides were investigated as marker ions
for the purpose of rapid identification of unknown
ADPRTs targets. These ions were selected based on
intensity and observed frequency from MS/MS analy-
ses of ADP-ribosylated Kemptide. Two of the ions, m6
and p5 (Scheme 2), are observed in CID tandem mass
spectra and the third, m1, is observed when using
IRMPD fragmentation.
Varying amounts of ADP-ribosylated Kemptide were
spiked into a BSA protein digest (see Limit of Detection)
for two reasons: (1) to determine a limit of detection and
(2) to assess whether m1, m6, and p5 fragment ions could
be used to accurately and reproducibly detect the
tandem mass spectra of ADP-ribosylated Kemptide in a
mixture of non-ribosylated peptides from BSA. Data
were acquired via a data-dependent ion selection
scheme that selected the top five ions per precursor ion
scan for tandem mass spectrometry (i.e., CID or
IRMPD). A limit of detection was determined for both
precursor ions and all three potential diagnostic
fragment ions. In all cases, the limit of detection was
determined to be femtomoles of ADP-ribosylated
Kemptide in the presence of picomoles of the protein
digest at a signal-to-noise ratio of 2:1.Tandem mass spectra from the spiking experiments
were sorted using PERL scripts that identified .dta files
containing each of the three specified marker ions within
10 ppm mass accuracy. Precursor ion masses of the .dta
files containing any one of these three diagnostic ions
were then compared to the known ADP-ribosylated
Kemptide mass. All observed precursor masses from
the three PERL script lists that were outside a mass
tolerance of 10 ppm were considered false positives.
Using this measure, initial false-positive rates of each
ion independent of the others were high: m6 95% (CID),
p5 66% (CID), and m1 92% (IRMPD). This is likely a
reflection of the commonality of these ions in many
tandemmass spectra. However, when precursor masses
identified from .dta files selected by the three PERL
scripts were used in combination rather than indepen-
dently, the resulting overall false-positive rate was
reduced to 0%. This same type of calculation changed
the false-negative rate from 0 to 8%. This suggests that
when trying to blindly screen tandem mass spectral
datasets for .dta files containing ions diagnostic of
ADP-ribose that one should include all three diagnostic
ions to maintain a low false-positive rate. Using frag-
ment ions diagnostic of ADP-ribose from both CID and
IRMPD data, we were able to successfully identify in an
automated manner (subsequently confirmed manually)
.dta files of ADP-ribosylated Kemptide spiked into a
digest of BSA. The same approach should be useful for
discovery work in more complex whole cell lysates,
although this may result in a higher false-positive rate.
Conclusions
Examination of three different fragmentation techniques
for the purpose of understanding ADP-ribosylated Kemp-
tide fragmentation patterns yielded tandem mass spec-
tra with both unique and shared fragment ions. Al-
though CID and IRMPD produced ions diagnostic of
ADP-ribose useful for determining whether a parent
mass contains ADP-ribose, the tandem mass spectra
lack significant peptide backbone fragmentation, thus
preventing identification of peptide sequence and mod-
ification site. Because ECD has been recognized as a
technique that provides peptide backbone fragmenta-
tion while allowing for retention of post-translational
modifications [13, 14], we investigated its utility for
sequencing ADP-ribosylated peptides. Our data clearly
demonstrated that ECD is the best fragmentation
method for determining peptide sequence and the site
of modification of ADP-ribosylated peptides. Electron-
transfer dissociation (ETD) [17], a fragmentation
method similar to ECD, may also provide sequence
information for an ADP-ribosylated peptide, but has
not been examined in this study. Disadvantages of
ECD, however, include a longer duty cycle and low
fragmentation efficiency relative to CID. Because of
these drawbacks, we recommend first using CID and
IRMPD fragmentation techniques to discover ADP-
ribosylated peptides with diagnostic ions, followed by
483J Am Soc Mass Spectrom 2009, 20, 477–483 TANDEM MS STUDY OF ADP-RIBOSYLATED KEMPTIDEtargeted ECD analyses to decipher the location of the
modification and the sequence of the peptide. This two-
step assay will allow for a more thorough analysis when
attempting to identify ADP-ribosylated targets com-
pared to using only shotgun proteomic analysis with
ECD alone.
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